Upstream Bio, Inc. (UPB)
29.86
+1.53
(+5.40%)
USD |
NASDAQ |
Dec 18, 16:00
29.78
-0.08
(-0.27%)
After-Hours: 20:00
Upstream Bio Profit Margin (Quarterly): -4.94K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
| IGC Pharma, Inc. | -953.4% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Protalix Biotherapeutics, Inc. | 13.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -31.77% |
| Return on Assets | -30.83% |
| Return on Invested Capital | -31.64% |
| Gross Profit Margin (Quarterly) | 95.46% |
| Operating Margin (Quarterly) | -5.54K% |
| Return on Net Operating Assets | -753.8% |